Fresenius Medical Care Corp (FMS)
$41.48
0.04 (0.10%)
FMS Stock Quote Delayed 30 Minutes
The Worst Appears to Be Over for CVS Stock
Over the years, CVS stock has incurred some painful losses in the markets. However, bold moves by management make this a compelling contrarian buy.
Louis Navellier's Top 6 Stocks for 2021
He found Apple at $1.49… Intel at $3.60... Amazon at $46. Now, investing legend Louis Navellier is revealing his Top 6 Stocks for 2021 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
12.15B
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
288,373
Day's Range
41.24 - 41.51
52-Week Range
33.84 - 46.55
Dividend & Yield
0.44 (1.05%)
FMS Stock Predictions, Articles, and Fresenius Medical Care Corp News
Solid Quant Score Keep Fresenius Medical Care (FMS) a Buy
The current recommendation of Buy for Fresenius Medical Care Corp (NYSE:FMS) has been derived by using Louis Navellier's methodology for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking FMS has had from Portfolio Grader for the last month.
Fresenius Medical Care’s (FMS) Solid Sales Growth Make it a Buy
Currently, Fresenius Medical Care Corp (NYSE:FMS) has a Buy using Louis Navellier's approach to investing and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for the last month.
Sales Growth Make Fresenius Medical Care (FMS) a Buy
Fresenius Medical Care Corp (NYSE:FMS) is a $29.7 billion in market value component of the Health Care Providers & Services GICS industry group where the ranking for FMS by Portfolio Grader places it 30 among the 82 companies in this industry group, giving it an above-average position. FMS is ranked in the top half of the sector with a ranking of 258 among the 785 companies in the sector and number 1,662 in the 5000 company Portfolio Grader company universe.
Fresenius Medical Care’s (FMS) Superior Quant Score Keeps it a Buy
Currently, Fresenius Medical Care Corp (NYSE:FMS) has a Buy using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. FMS has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.
Fresenius Medical Care (FMS) a Buy on Healthy Earnings Visibility
Fresenius Medical Care Corp (NYSE:FMS) ranks in the top 10% of its industry group, Health Care Providers & Services, and in the top decile of sector group, Health Care, with a market value of $30.0 billion. From an investment attractiveness prospective, FMS is ranked in the top quartile of the sector with a ranking of 169 among the 782 companies in the sector; the stock's Portfolio Grader ranking places it 20 among the 82 companies in this industry group, giving it a well above-average position and number 1,197 in the 5000 company Portfolio Grader company universe.
Fresenius Medical Care’s (FMS) Solid Earnings Visibility Keeps it a Buy
Fresenius Medical Care Corp (NYSE:FMS) ranks in the top decile in its industry group, Health Care Providers & Services, and in the top decile of sector group, Health Care, with a market value of $29.5 billion. From an investment attractiveness prospective, FMS is ranked in the top half of the sector with a ranking of 227 among the 783 companies in the sector; Portfolio Grader's current ranking for FMS puts it 24 among the 83 companies in this industry group, placing it in the top half and number 1,627 in the 5000 company Portfolio Grader company universe.
Hold Recommendation on Fresenius Medical Care (FMS) Stock Extended
The current recommendation of Hold for Fresenius Medical Care Corp (NYSE:FMS) has been derived by using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. FMS has maintained this ranking for 4 months.
Hold Recommendation on Fresenius Medical Care (FMS) Stock Extended
The current recommendation of Hold for Fresenius Medical Care Corp (NYSE:FMS) has been derived by using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. FMS has maintained this ranking for 4 months.
Akorn, Inc. (AKRX) Stock Soars on Possible Fresenius Deal
Akorn (AKRX) shares soared on Monday on the news that the company may soon be the subject of a buyout. Here's what you should know about it.
17 Health Care Providers & Services Stocks to Sell Now
The ratings of 17 Health Care Providers & Services stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
10 Health Care Providers & Services Stocks to Sell Now
The ratings of 10 Health Care Providers & Services stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
3 Health Care Providers & Services Stocks to Buy Now
The grades of 3 Health Care Providers & Services stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.
6 Health Care Providers & Services Stocks to Buy Now
The grades of 6 Health Care Providers & Services stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
70 Actions to Take on Monday’s Rally
During these busy times it pays to stay on top of the latest profit opportunities. Today's blog post features my latest Portfolio Grader rankings
40 Upgrades and Downgrades for this Week
It pays to stay on top of the latest profit opportunities, and today's post is a great place to start. Here are Portfolio Grader's latest stock updates
6 Health Care Providers & Services Stocks to Buy Now
The grades of 6 Health Care Providers & Services stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
These 68 Blue Chips Are on the Move
During these times it pays to stay on top of the latest profit opportunities. Today's blog post is a great place to start with these blue chip stock moves
Hottest Healthcare Stocks Now – MDT CMN JNJ BMY
Healthcare stocks fell 0.2% on Wall Street on Tuesday morning.
6 Health Care Provider Stocks to Buy Now
Six health care provider stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").
